Quick Answer
Vera Therapeutics, Inc. reported Total Assets of $734.73 million for fiscal year 2025.
Vera Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $734.73M | +12.1% |
| 2024 | $655.68M | +273.5% |
| 2023 | $175.55M | +33.6% |
| 2022 | $131.44M | +56.9% |
| 2021 | $83.75M | +53.5% |
| 2020 | $54.55M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $517.50M | +40.4% | -10.5% |
| June 30, 2025 | $578.53M | +45.6% | -5.2% |
| March 31, 2025 | $610.17M | +45.5% | -6.9% |
| December 31, 2024 | $655.68M | +273.5% | +77.9% |
| September 30, 2024 | $368.56M | +109.9% | -7.2% |
| June 30, 2024 | $397.29M | +103.6% | -5.3% |
| March 31, 2024 | $419.36M | +100.1% | +138.9% |
| December 31, 2023 | $175.55M | +33.6% | -0.0% |
- Vera Therapeutics, Inc. showed an increase of +12.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Vera Therapeutics, Inc.’s total assets has grown by 1246.8% (from $54.55 million to $734.73 million).
- The most recent figure is from Vera Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: